Cost-effectiveness of a Novel Hypoglycaemia Programme: The 'HARPdoc vs BGAT' RCT.
Healey A, Soukup T, Sevdalis N, Bakolis I, Cross S, Heller SR, Brooks A, Kariyawasam D, Toschi E, Gonder-Frederick L, Stadler M, Rogers H, Goldsmith K, Choudhary P, de Zoysa N, Amiel SA; HARPdoc RCT Study Group.
Healey A, et al. Among authors: rogers h.
Diabet Med. 2024 Jun;41(6):e15304. doi: 10.1111/dme.15304. Epub 2024 Feb 29.
Diabet Med. 2024.
PMID: 38421806
Clinical Trial.